News und Analysen

Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA^® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from

Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet^® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,¹ neurokinin 1 (NK1)

Bayer will present methods and baseline characteristic data from the global Phase III OCEANIC-STROKE study with the investigational agent asundexian, in a late-breaking presentation at the upcoming

Bayer is proud to announce that Cornfed Farms, a fourth-generation farm operated by the Mohr family, has been designated as the first Bayer ForwardFarm site in the Midwest and the only ForwardFarm

Bayer AG and its wholly owned, independently operated subsidiary BlueRock Therapeutics LP, a clinical stage cell therapy company, today announced positive 36-month data from exPDite, a Phase I

The Consumer Health division of Bayer has selected Interpublic Group (NYSE: IPG) as the global agency partner for all creative, production and media, responsible for marketing activities for some

Bayer announced today that data from across the KERENDIA^® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific

Bayer announced today progress for two potential therapies against Parkinson’s disease (PD). A first participant received randomized treatment in the pivotal Phase III clinical trial, exPDite-2, of

Bayer today announced that a New Drug Application (NDA) for its investigational contrast agent gadoquatrane has been accepted for review by the U.S. Food and Drug Administration (FDA). The NDA for

Monsanto has now reached agreements in principle to resolve all Sky Valley Education Center cases, representing more than 200 plaintiffs overall, with the exception of the prior adverse verdicts

Bayer’s Aspirina, the #1 pain relief option in Mexico¹, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. With a deep commitment to Hispanic

Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is revolutionizing the power delivery architecture required for future AI data centers. In collaboration with NVIDIA, Infineon is developing the

Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is accelerating the build-up of its system capabilities for software-defined vehicles with the acquisition of Marvell Technology’s Automotive

Stabhochsprung-Weltrekordhalter Armand „Mondo“ Duplantis glaubt, den Weltrekord im Stabhochsprung in den nächsten Jahren auf 6,40 Meter verbessern zu können. Das sagte der Athlet im Gespräch mit

Pole vault world-record holder Armand “Mondo” Duplantis believes he can push the pole-vault world record to 6.40 metres in the next few years, the athlete said in a conversation with PUMA CEO Arne

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch of one of the